Hong, NH. et al. Advances in the Development of a Targeted N-Terminal Domain Androgen Receptor Degrader (ANITAC) for the Treatment of Prostate Cancer. Prostate Cancer Foundation (PCF) 2022 Scientific Retreat.

Read More > PCF 2022 Poster Presentation